ASX Filings

Ceasing to be a substantial holder

October 29, 2019

Opthea Clinical Data Published in Leading Ophthalmic Journal

October 29, 2019

Becoming a substantial holder

October 24, 2019

Notice of Annual General Meeting and Proxy Form

October 18, 2019

Appendix 4G and Corporate Governance Statement 2019

October 18, 2019

Annual Report 2019

October 18, 2019

Opthea Presents Additional Data from Ph2b Trial at OIS in US

October 11, 2019

Opthea Presentation for Ophthalmology Innovation Summit

October 10, 2019

Change in substantial holding

October 9, 2019

Becoming a substantial holder

October 8, 2019